Catheter Precision (FRA:4RM) Float Percentage Of Total Shares Outstanding: 95.75% (As of Jul. 05, 2026)


FRA:4RM Catheter Precision Inc FRA:4RM
23 GF Score
Price €100.89
GF Value €218.38
! 7 Warning Signs
View Full Analysis

What is Catheter Precision Float Percentage Of Total Shares Outstanding?

Catheter Precision FRA:4RM 23 Float Percentage Of Total Shares Outstanding is 95.75% as of Jul. 05, 2026. GuruFocus rates FRA:4RM with a GF Score™ of 23/100 and a GF Value™ of €218.38. The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Catheter Precision's float shares is 2.58 Mil. Catheter Precision's total shares outstanding is 2.69 Mil. Catheter Precision's float percentage of total shares outstanding is 95.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Catheter Precision's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Catheter Precision's Institutional Ownership is 1.86%.

FRA:4RM
23GF Score
Catheter Precision Inc FRA:4RM
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Catheter Precision Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Catheter Precision's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.58/2.69
=95.75%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 95.75% mean?
Catheter Precision (FRA:4RM) has a Float Percentage Of Total Shares Outstanding of 95.75% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Catheter Precision and its competitors.
Is Catheter Precision's Float Percentage Of Total Shares Outstanding too high?
Catheter Precision's current Float Percentage Of Total Shares Outstanding is 95.75%. Overall, Catheter Precision has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Float Percentage Of Total Shares Outstanding compare to ALURD and BJDX?
Catheter Precision's Float Percentage Of Total Shares Outstanding of 95.75% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Catheter Precision and its competitors. Catheter Precision's current Float Percentage Of Total Shares Outstanding is 95.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current Float Percentage Of Total Shares Outstanding of 95.75%. The stock's GF Value™ is €218.38, compared to a current price of €100.89 — trading 53.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 95.75%. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current Float Percentage Of Total Shares Outstanding is 95.75% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Catheter Precision (FRA:4RM) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of €100.89 is trading 53.8% below its estimated GF Value™ of €218.38.

Key valuation signals for FRA:4RM:

  • Float Percentage Of Total Shares Outstanding: 95.75%
  • GF Value™: €218.38 vs. price of €100.89 (53.8% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Other Exchanges VTAK:USA
Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score

Get the complete analysis for FRA:4RM

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€100.89
Price
€218.38
GF Value